Harborside


Cannara Biotech Inc.

CVE: LOVE


Canadian symbol: LOVE.V
US symbol: LOVFF

Currency in CAD

Valuation Measures4

Market Cap (intraday) 100.85M
Enterprise Value 128.26M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.30
Price/Book (mrq)1.57
Enterprise Value/Revenue 4.24
Enterprise Value/EBITDA 21.17

Trading Information

Stock Price History

Beta (5Y Monthly) 1.52
52-Week Change 3-23.33%
S&P500 52-Week Change 3-16.88%
52 Week High 30.1550
52 Week Low 30.0950
50-Day Moving Average 30.1082
200-Day Moving Average 30.1164

Share Statistics

Avg Vol (3 month) 3134.21k
Avg Vol (10 day) 393.64k
Shares Outstanding 5876.98M
Implied Shares Outstanding 6N/A
Float 8454.77M
% Held by Insiders 147.01%
% Held by Institutions 10.00%
Shares Short (Sept 14, 2022) 432.33k
Short Ratio (Sept 14, 2022) 40.27
Short % of Float (Sept 14, 2022) 4N/A
Short % of Shares Outstanding (Sept 14, 2022) 40.00%
Shares Short (prior month Aug 14, 2022) 476.6k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Aug 30, 2021
Most Recent Quarter (mrq)May 30, 2022

Profitability

Profit Margin 2.92%
Operating Margin (ttm)8.30%

Management Effectiveness

Return on Assets (ttm)1.91%
Return on Equity (ttm)1.76%

Income Statement

Revenue (ttm)30.29M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)40.60%
Gross Profit (ttm)10.3M
EBITDA 5.94M
Net Income Avi to Common (ttm)883.82k
Diluted EPS (ttm)0.0010
Quarterly Earnings Growth (yoy)-15.90%

Balance Sheet

Total Cash (mrq)3.88M
Total Cash Per Share (mrq)0
Total Debt (mrq)31.29M
Total Debt/Equity (mrq)48.75
Current Ratio (mrq)2.13
Book Value Per Share (mrq)0.07

Cash Flow Statement

Operating Cash Flow (ttm)-1.53M
Levered Free Cash Flow (ttm)-41.2M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
LOVE.V
Cannara Biotech
2 weeks ago
LOVE.V
Cannara Biotech
3 weeks ago
LOVE.V
Cannara Biotech
2 months ago
LOVE.V
Cannara Biotech
2 months ago
LOVE.V
Cannara Biotech
3 months ago
LOVE.V
Cannara Biotech
3 months ago
LOVE.V
Cannara Biotech
5 months ago
LOVE.V
Cannara Biotech
5 months ago
LOVE.V
Cannara Biotech
7 months ago
LOVE.V
Cannara Biotech
7 months ago
LOVE.V
Cannara Biotech
10 months ago
LOVE.V
Cannara Biotech
1 year ago
LOVE.V
Cannara Biotech
1 year ago
LOVE.V
Cannara Biotech
1 year ago
LOVE.V
Cannara Biotech
1 year ago
LOVE.V
Cannara Biotech
1 year ago
LOVE.V
Cannara Biotech
2 years ago
LOVE.V
Cannara Biotech
2 years ago
LOVE.V
Cannara Biotech
2 years ago
LOVE.V
Cannara Biotech
2 years ago
LOVE.V
Cannara Biotech
3 years ago
LOVE.V
Cannara Biotech
3 years ago
LOVE.V
Cannara Biotech
3 years ago
LOVE.V
Cannara Biotech
3 years ago
LOVE.V
Cannara Biotech
3 years ago
LOVE.V
Cannara Biotech
3 years ago
LOVE.V
Cannara Biotech
3 years ago
LOVE.V
Cannara Biotech
3 years ago
LOVE.V
Cannara Biotech
3 years ago
LOVE.V
Cannara Biotech
3 years ago
LOVE.V
Cannara Biotech
3 years ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
47.01%% of Shares Held by All Insider
0.00%% of Shares Held by Institutions
0.00%% of Float Held by Institutions
0Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Cannara Biotech Inc.


Cannara Biotech Inc. Announces Entry into the British Columbia Market and the Launch of its First Vape Cartridge and Vape Accessory, Tribal G Mint and UNI Pro Ark

Cannara Biotech Inc. Announces Entry into the British Columbia Market and the Launch of its First Vape Cartridge and Vape Accessory, Tribal G Mint and UNI Pro Ark

MONTREAL, Sept. 20, 2022 - Cannara Biotech Inc. ("Cannara") (TSXV: LOVE) ( OTCQB: LOVFF) (FRA: 8CB), a Quebec-based, vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices, today announced its entry into the British Columbia (BC) market.  In addition, the Company is also pleased to a... Read More...
Cannara signs an Exclusive Brand Partnership with Exotic Genetix in Canada

Cannara signs an Exclusive Brand Partnership with Exotic Genetix in Canada

Agreement grants Cannara an exclusive license to use, sell and distribute Exotic Genetix branded products throughout  Canada in addition to providing access to direct breeder's knowledge and insights on Exotic Genetix' cannabis strains MONTREAL, Aug. 3, 2022 - Cannara Biotech Inc. ("Cannara") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vert... Read More...
Cannara Biotech Inc. Reports Fiscal Third Quarter 2022 Financial Results

Cannara Biotech Inc. Reports Fiscal Third Quarter 2022 Financial Results

Company recorded a record high of $10.1 million in quarterly revenue and $24.1 million in year-to-date revenue, delivering its fifth consecutive quarter of positive Q3 2022 Adjusted EBITDA of $1.8M with net income of $1.4 million Valleyfield Facility continues to scale, and the Company now has 6 of its 24 growing zones in full production ... Read More...
Cannara Biotech Inc. Closes $50 Million Credit Facility Led by BMO Commercial Banking

Cannara Biotech Inc. Closes $50 Million Credit Facility Led by BMO Commercial Banking

MONTREAL, June 1, 2022 /CNW Telbec/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., announced today that it has closed on a $50M credit fac... Read More...
Cannara Biotech Inc. to Present at Canaccord Genuity's 6th Annual Cannabis Conference on May 11th and Retains Bristol Capital for Investor Relations Services

Cannara Biotech Inc. to Present at Canaccord Genuity’s 6th Annual Cannabis Conference on May 11th and Retains Bristol Capital for Investor Relations Services

MONTREAL, May 4, 2022 -¬†Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega¬† facilities based in QueŐĀbec spanning over 1,650,000 sq. ft., today announced the Company's Chief Financial Officer, Nicholas Sos... Read More...
Cannara Biotech Inc. Reports Fiscal Second Quarter 2022 Financial Results

Cannara Biotech Inc. Reports Fiscal Second Quarter 2022 Financial Results

Posted quarterly revenues of $7.4 million, an increase of 229% from the same quarter in the previous year; Recorded a gross profit before fair value adjustments of $2.6 million or 36% more than the same quarter in the previous year; Achieved fourth consecutive quarter of positive Adjusted EBITDA while significantly expanding its producti... Read More...
Cannara Biotech Inc. Reports Fiscal First Quarter 2022 Financial Results

Cannara Biotech Inc. Reports Fiscal First Quarter 2022 Financial Results

MONTREAL, January 20, 2022 /CNW Telbec/ -¬†Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in QueŐĀbec spanning over 1,650,000 sq. ft., today announced its fiscal first quarter of 2022 ... Read More...
Cannara Biotech Inc. Reports Fourth Quarter and Fiscal Year 2021 Results

Cannara Biotech Inc. Reports Fourth Quarter and Fiscal Year 2021 Results

Fiscal 2021 revenues of $17.3 million, gross profit of $10.5 million or 61% and an Adjusted EBITDA of $1.5 million, strong indicators of Cannara's performance and successful operating strategy All financial results are reported in Canadian dollars, unless otherwise stated. MONTREAL, Dec. 8, 2021 - Cannara Biotech Inc. ("Cannara" or the "... Read More...
Cannara's Valleyfield Facility Receives Processing and Cultivation License

Cannara’s Valleyfield Facility Receives Processing and Cultivation License

10 000 plants to be propagated in the re-designed Valleyfield zones to replicate indoor growing conditions MONTREAL, Sept. 27, 2021 /CNW Telbec/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega cultiv... Read More...
Cannara Biotech Inc. Receives Amendment of its Licence from Health Canada Permitting the Sale of Cannabis 2.0 Products and Prepares for the Launch of its Hash Product Line in Quebec

Cannara Biotech Inc. Receives Amendment of its Licence from Health Canada Permitting the Sale of Cannabis 2.0 Products and Prepares for the Launch of its Hash Product Line in Quebec

Cannara is excited to announce the first expansion of its Nugz product line: OId School Hash and Ice Water Hash. These two products will first be launched in Quebec and have been specifically formulated for the Quebec market to provide quality hash that contains less than 30% THC. Both products are expected to be available to consumers i... Read More...
Cannara Biotech Inc. Reports Strong First Quarterly Profit Driven by Retail Debut

Cannara Biotech Inc. Reports Strong First Quarterly Profit Driven by Retail Debut

Third quarter revenue of $7.2 million, gross profit of $4.4 million, and net income of $1.7 millionshowcases success of market strategy and operating model MONTREAL, July 28, 2021 /CNW Telbec/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade canna... Read More...
Cannara Biotech Inc. Completes Additional $5 Million Private Placement

Cannara Biotech Inc. Completes Additional $5 Million Private Placement

MONTREAL, July 9, 2021 - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium‚Äďgrade cannabis and derivative products with two Quebec‚Äďbased mega cultivation facilities spanning over 1,650,000 sq. ft., today announced that it has closed an additional $5 million... Read More...
Cannara Biotech Inc. Completes Acquisition of TGOD's State-of-the-art Cultivation and Manufacturing Facility in Valleyfield, Quebec

Cannara Biotech Inc. Completes Acquisition of TGOD’s State-of-the-art Cultivation and Manufacturing Facility in Valleyfield, Quebec

Newly built fully automated one million sq. ft. facility increases Company's production capacity of premium-grade cannabis up to 125,000 kg annually MONTREAL, June 23, 2021 - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivativ... Read More...
Cannara Biotech Inc. Enters into Definitive Agreement to Acquire TGOD's State-of-the-Art Cultivation and Manufacturing Facility in Valleyfield, Quebec

Cannara Biotech Inc. Enters into Definitive Agreement to Acquire TGOD’s State-of-the-Art Cultivation and Manufacturing Facility in Valleyfield, Quebec

Newly built fully automated one million sq. ft. facility increases Company's capacity of premium-grade cannabis up to 125,000 kg annually MONTREAL, June 10, 2021 - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products wi... Read More...
Cannara Biotech Enters Into Agreement to Acquire TGOD's State-of-the-art Cultivation and Manufacturing Facility in Valleyfield, Quebec

Cannara Biotech Enters Into Agreement to Acquire TGOD’s State-of-the-art Cultivation and Manufacturing Facility in Valleyfield, Quebec

Newly built fully automated one million sq. ft. facility increases Company's capacity of premium-grade cannabis up to 125,000 kg annually MONTREAL, June 10, 2021 - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products wi... Read More...
Cannara Biotech Secures Conditional Approval to List on the TSX Exchange

Cannara Biotech Secures Conditional Approval to List on the TSX Exchange

Anticipated TSXV market listing coincides with the appointment of Nicholas Sosiak to CFO and retail market debut MONTREAL, March 11, 2021 - Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated Quebec-based producer of premium-grade indoor cannabis and derivative products with one of the largest i... Read More...
Cannara Biotech Inc. Reports Q1 2021 Financial Results

Cannara Biotech Inc. Reports Q1 2021 Financial Results

- Expects to generate revenue from letter of intent with the Société québécoise du cannabis by end of February or early March 2021 - MONTREAL, Jan. 29, 2021 - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB) is pleased to announce its financial results for the three-month period ended November 30, 20... Read More...
Cannara enters LOI with SQDC for Entire First Year Production

Cannara enters LOI with SQDC for Entire First Year Production

- Operations Accelerating with 100th Quebec Employee Hired - MONTREAL, July 6, 2020 - Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB) announced today it has finalized a non-binding Letter of Intent (LOI) with the Société québécoise du cannabis (the "SQDC"). With this LOI, Cannara will dedicate its entire first year ... Read More...
Cannara Harvests First Crop on 420

Cannara Harvests First Crop on 420

300 kgs of Carefully Crafted Premium Indoor Cannabis Marks Pivotal Milestone VANCOUVER, April 20, 2020 - Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and sale of premium dried cannabis and cannabis-derivative products, t... Read More...
Cannara Insiders Form Buying Group to Fully Acquire FSD/FV Pharma's Position in Cannara

Cannara Insiders Form Buying Group to Fully Acquire FSD/FV Pharma’s Position in Cannara

Insiders' increase stake in Cannara coincides as cultivation poised to commence VANCOUVER, Feb. 20, 2020 - Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), today announced a buying group which includes Javaa Private Equity Inc. ("Javaa") has collectively acquired a total of 85,003,250 common shares from FSD/FV Pharm... Read More...
Lennie Ryer and Barry Laxer of Cannara Biotech Inc. are Featured On The Stock Day Podcast

Lennie Ryer and Barry Laxer of Cannara Biotech Inc. are Featured On The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - February 6, 2020) - The Stock Day Podcast welcomed Cannara Biotech Inc. (OTCQB: LOVFF) ("the Company"), a company building one of the largest indoor cannabis cultivation facilities (625,000 square feet) in Canada and the largest in Québec. Lennie Ryer and Barry Laxer joined Stock Day host Everett Jolly.... Read More...
Cannara Biotech Reports Q4 and Year-End 2019 Financial Results

Cannara Biotech Reports Q4 and Year-End 2019 Financial Results

VANCOUVER, Nov. 26, 2019 - Cannara Biotech Inc. ("Cannara") (CSE: LOVE) (FRA: 8CB) (OTCQB: LOVFF), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and sale of premium cannabis and cannabis-infused products, today announced financial results for the three month period and year ended August 31, 2... Read More...
Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce

Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce

VANCOUVER, Oct. 10, 2019 - Cannara Biotech Inc. ("Cannara Biotech") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of premium cannabis and cannabis-infused products, announced it has secured a first mortgage against its Farnham Facility in the value of $6 mi... Read More...
Cannara Biotech Submits Site Evidence Package to Health Canada for its Quebec Facility

Cannara Biotech Submits Site Evidence Package to Health Canada for its Quebec Facility

VANCOUVER, Sept. 12, 2019 - Cannara Biotech Inc. ("Cannara Biotech") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of  premium cannabis and cannabis-infused products, announced it has submitted to Health Canada its site evidence package for Phase One o... Read More...
Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares

Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares

VANCOUVER, July 12, 2019 - Cannara Biotech Inc. (the "Corporation" or "Cannara") (CSE: LOVE) (FRA: 8CB) (OTCMKTS: LOVFF), an emerging vertically integrated cannabis company focused on cultivation, and cannabis-infused products, is pleased to announce that it has raised $2,160,000 by way of non-brokered private placement of common shares o... Read More...
Psiq Announces Reseller Agreement With Cannara Biotech Subsidiary Shopcbd.com To Market And Sell Elites Cbd Product Line Within The United States

Psiq Announces Reseller Agreement With Cannara Biotech Subsidiary Shopcbd.com To Market And Sell Elites Cbd Product Line Within The United States

SUNRISE, Fla., April 30, 2019 -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc. (‚ÄúElite‚ÄĚ), has entered into a Reseller Agreement with Shopcbd.com, a subsidiary of Cannara Biotech, Inc. (CSE: "LOVE") (FRA: "8CB") to market and sell Elite‚Äôs line of products withi... Read More...
Cannara Biotech Subsidiary Global shopCBD.com Raises in Excess of $8.8 Million to Fuel U.S. Hemp-CBD E-Commerce Platform

Cannara Biotech Subsidiary Global shopCBD.com Raises in Excess of $8.8 Million to Fuel U.S. Hemp-CBD E-Commerce Platform

MONTREAL , March 26, 2019 - Cannara Biotech Inc. ("Cannara") (LOVE.CN) (8CB.F), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced its subsidiary Global shopCBD.com Inc. ("shopCBD.com") has closed private rounds of financing for aggregate proceeds of $8,865,849.15 (the ... Read More...
Coming Soon.
IndexLast% Change
S&P 5003,693.23--
Euro STOXX 503,346.270.07%Negative
FTSE 1006,959.630.84%Negative
Nikkei 22526,431.552.66%Negative

Delayed data (1h)
IndexLast% Change
S&P 5003,693.23--
Euro STOXX 503,346.270.07%Negative
FTSE 1006,959.630.84%Negative
Nikkei 22526,431.552.66%Negative


Share this page